Gerald Posner
Pulitzer finalist, investigative journalist and author
Gerald Posner spent years mapping the pharmaceutical industry's grip on medicine, regulators, and the press. When he turned that lens on gender medicine, what he found was not surprising — it was damning. His conversation with Stella, Mia, and Bret is a masterclass in following the money through one of medicine's most contested frontiers.
Gerald Posner is a former attorney turned investigative journalist whose decades of forensic research have taken him from Nazi war-crimes documentation to the boardrooms of Big Pharma. A Pulitzer Prize finalist for Case Closed, his landmark work Pharma: Greed, Lies, and the Poisoning of America established him as one of the sharpest chroniclers of how pharmaceutical profit corrupts medicine, regulation, and the journalism meant to scrutinise both.
In episode fifteen of Beyond Gender, Why Journalists Won't Investigate the Trans Medical Industry, Posner brings that same forensic discipline to gender medicine. Joining Stella O'Malley, Mia Hughes, and Dr Bret Alderman, he traces the commercial logic driving the prescription of puberty blockers and cross-sex hormones to minors — an infrastructure of financial incentives, institutional capture, and reputational risk that he argues has produced in gender clinics exactly what he documented in mainstream pharmaceuticals: a system where profit motive consistently overrides patient welfare.
What makes the episode especially striking is Posner's analysis of media silence. Drawing on his experience navigating advertiser pressure and editorial capture across decades of pharmaceutical reporting, he maps the structural reasons mainstream journalists have avoided this story — and names the cost borne by patients when the watchdog stays quiet.
Posner's appearance on Beyond Gender is a reminder that the gender medicine debate is not a culture-war novelty but the latest chapter in a much longer story about what happens when vulnerable patients meet an industry that has learned, very effectively, how to keep scrutiny at bay.
